Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212

1.

Diagnosis and treatment of familial hypercholesterolaemia.

Hovingh GK, Davidson MH, Kastelein JJ, O'Connor AM.

Eur Heart J. 2013 Apr;34(13):962-71. doi: 10.1093/eurheartj/eht015. Epub 2013 Feb 14. Review.

PMID:
23416791
[PubMed - indexed for MEDLINE]
Free Article
2.

Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.

Miltiadous G, Xenophontos S, Bairaktari E, Ganotakis M, Cariolou M, Elisaf M.

Pharmacogenet Genomics. 2005 Apr;15(4):219-25.

PMID:
15864114
[PubMed - indexed for MEDLINE]
3.
4.

The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.

Jensen HK.

Dan Med Bull. 2002 Nov;49(4):318-45. Review.

PMID:
12553167
[PubMed - indexed for MEDLINE]
5.

Therapeutic potential of mipomersen in the management of familial hypercholesterolaemia.

Gelsinger C, Steinhagen-Thiessen E, Kassner U.

Drugs. 2012 Jul 30;72(11):1445-55. doi: 10.2165/11635060-000000000-00000.

PMID:
22799743
[PubMed - indexed for MEDLINE]
6.

Familial hypercholesterolaemia: optimum treatment strategies.

Ballantyne CM.

Int J Clin Pract Suppl. 2002 Jul;(130):22-6. Review.

PMID:
12296605
[PubMed - indexed for MEDLINE]
7.

Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to high-dose statin therapy.

Raal F, Panz V, Immelman A, Pilcher G.

J Am Heart Assoc. 2013 Apr 24;2(2):e000028. doi: 10.1161/JAHA.112.000028.

PMID:
23537802
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia.

Pisciotta L, Sallo R, Rabacchi C, Wunsch A, Calandra S, Bertolini S.

Nutr Metab Cardiovasc Dis. 2012 Oct;22(10):831-5. doi: 10.1016/j.numecd.2011.04.003. Epub 2011 Sep 14.

PMID:
21920719
[PubMed - indexed for MEDLINE]
9.

Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.

Huijgen R, Kindt I, Verhoeven SB, Sijbrands EJ, Vissers MN, Kastelein JJ, Hutten BA.

PLoS One. 2010 Feb 15;5(2):e9220. doi: 10.1371/journal.pone.0009220.

PMID:
20169164
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Genetic analysis of familial hypercholesterolaemia in Western Australia.

Hooper AJ, Nguyen LT, Burnett JR, Bates TR, Bell DA, Redgrave TG, Watts GF, van Bockxmeer FM.

Atherosclerosis. 2012 Oct;224(2):430-4. doi: 10.1016/j.atherosclerosis.2012.07.030. Epub 2012 Jul 27.

PMID:
22883975
[PubMed - indexed for MEDLINE]
11.

The management of familial hypercholesterolaemia in Morocco.

El Messal M, Aït Chihab K, Chater R, Loutfi M, Kettani A, Hafidi A, Adlouni A.

Acta Cardiol. 2006 Oct;61(5):551-5. Review.

PMID:
17117756
[PubMed - indexed for MEDLINE]
12.

Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.

Raal FJ, Santos RD.

Atherosclerosis. 2012 Aug;223(2):262-8. doi: 10.1016/j.atherosclerosis.2012.02.019. Epub 2012 Feb 16. Review.

PMID:
22398274
[PubMed - indexed for MEDLINE]
14.

PCSK9: From discovery to therapeutic applications.

Farnier M.

Arch Cardiovasc Dis. 2014 Jan;107(1):58-66. doi: 10.1016/j.acvd.2013.10.007. Epub 2013 Dec 27. Review.

PMID:
24373748
[PubMed - indexed for MEDLINE]
Free Article
16.

Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R).

Schaefer JR, Kurt B, Sattler A, Klaus G, Soufi M.

Clin Res Cardiol Suppl. 2012 Jun;7(Suppl 1):2-6.

PMID:
22528129
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways.

Cameron J, Bogsrud MP, Tveten K, Strøm TB, Holven K, Berge KE, Leren TP.

Transl Res. 2012 Aug;160(2):125-30. doi: 10.1016/j.trsl.2012.01.010. Epub 2012 Jan 31.

PMID:
22683370
[PubMed - indexed for MEDLINE]
18.
19.

Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic.

Tosi I, Toledo-Leiva P, Neuwirth C, Naoumova RP, Soutar AK.

Atherosclerosis. 2007 Sep;194(1):102-11. Epub 2006 Nov 13.

PMID:
17094996
[PubMed - indexed for MEDLINE]
20.

Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia.

Bell DA, Hooper AJ, Watts GF, Burnett JR.

Vasc Health Risk Manag. 2012;8:651-9. doi: 10.2147/VHRM.S28581. Epub 2012 Nov 28. Review.

PMID:
23226021
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk